University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Azacitidine Combinations in Myeloid Malignancies: Is Aza/Pevonidistat More Effective than Azacitidine Monotherapy in Higher-Risk MDS/CMML/AML? How Effective Is Aza/Magrolimab Combination in Untreated AML/MDS?
Login to view comments.
Click here to Login